| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 14 | 2016 | 35 | 3.500 |
Why?
|
| Lung | 25 | 2014 | 484 | 2.760 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 16 | 2012 | 31 | 2.440 |
Why?
|
| Guinea Pigs | 37 | 2016 | 144 | 1.740 |
Why?
|
| Antioxidants | 8 | 2016 | 439 | 1.570 |
Why?
|
| Lung Injury | 4 | 2016 | 18 | 1.430 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2010 | 69 | 1.110 |
Why?
|
| Receptors, GABA-A | 7 | 2010 | 65 | 1.020 |
Why?
|
| Liposomes | 6 | 2016 | 130 | 0.970 |
Why?
|
| Chemical Warfare Agents | 4 | 2011 | 14 | 0.970 |
Why?
|
| Animals | 53 | 2016 | 16695 | 0.790 |
Why?
|
| Tretinoin | 2 | 2014 | 50 | 0.770 |
Why?
|
| Benzodiazepinones | 9 | 2012 | 21 | 0.720 |
Why?
|
| Acetylcysteine | 3 | 2009 | 57 | 0.690 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2003 | 54 | 0.670 |
Why?
|
| Lung Diseases | 4 | 2006 | 62 | 0.660 |
Why?
|
| Phosphotransferases | 3 | 2014 | 35 | 0.610 |
Why?
|
| Receptors, GABA | 2 | 2012 | 28 | 0.600 |
Why?
|
| Transcription Factor AP-1 | 2 | 2009 | 31 | 0.600 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 5 | 2010 | 28 | 0.560 |
Why?
|
| Soybean Proteins | 2 | 2008 | 38 | 0.530 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 26 | 0.520 |
Why?
|
| Carrier Proteins | 2 | 2010 | 318 | 0.490 |
Why?
|
| Signal Transduction | 3 | 2014 | 2111 | 0.490 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 1679 | 0.460 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2009 | 35 | 0.450 |
Why?
|
| Retinoids | 1 | 2014 | 25 | 0.450 |
Why?
|
| Erythrocytes | 5 | 2011 | 126 | 0.450 |
Why?
|
| Microsomes | 6 | 2005 | 55 | 0.420 |
Why?
|
| Carcinogens | 4 | 2008 | 126 | 0.400 |
Why?
|
| Models, Biological | 2 | 2014 | 711 | 0.380 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 164 | 0.380 |
Why?
|
| Lactoylglutathione Lyase | 2 | 2002 | 4 | 0.380 |
Why?
|
| Thiolester Hydrolases | 2 | 2002 | 7 | 0.380 |
Why?
|
| Male | 31 | 2016 | 22779 | 0.380 |
Why?
|
| Superoxide Dismutase | 7 | 2006 | 158 | 0.370 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 979 | 0.370 |
Why?
|
| Blotting, Western | 7 | 2010 | 884 | 0.360 |
Why?
|
| Liver | 5 | 2002 | 503 | 0.360 |
Why?
|
| Cell Proliferation | 4 | 2012 | 1420 | 0.360 |
Why?
|
| Smoking | 3 | 2007 | 1019 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 167 | 0.340 |
Why?
|
| Epithelial Cells | 2 | 2004 | 426 | 0.320 |
Why?
|
| Isoquinolines | 1 | 2010 | 50 | 0.320 |
Why?
|
| Antidotes | 1 | 2009 | 2 | 0.310 |
Why?
|
| Brain Injuries | 1 | 2011 | 133 | 0.310 |
Why?
|
| Mitochondria | 6 | 2001 | 516 | 0.310 |
Why?
|
| Phosphatidylcholines | 3 | 2005 | 35 | 0.310 |
Why?
|
| Pulmonary Alveoli | 3 | 2002 | 27 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 1737 | 0.310 |
Why?
|
| Kidney | 2 | 2002 | 363 | 0.310 |
Why?
|
| Tocopherols | 1 | 2009 | 61 | 0.300 |
Why?
|
| Rats | 11 | 2010 | 3701 | 0.300 |
Why?
|
| Lutein | 1 | 2008 | 6 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 136 | 0.290 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 63 | 0.290 |
Why?
|
| Triiodothyronine | 3 | 2001 | 36 | 0.280 |
Why?
|
| Brain | 4 | 2011 | 1452 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 457 | 0.260 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 557 | 0.250 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 189 | 0.250 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 261 | 0.250 |
Why?
|
| Anthracenes | 1 | 2006 | 15 | 0.250 |
Why?
|
| Dietary Proteins | 1 | 2006 | 35 | 0.250 |
Why?
|
| Sequence Alignment | 2 | 2003 | 273 | 0.250 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 29 | 0.250 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2005 | 15 | 0.240 |
Why?
|
| Breast | 2 | 2006 | 139 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 137 | 0.230 |
Why?
|
| Transcription Factors | 1 | 2010 | 722 | 0.230 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2010 | 49 | 0.230 |
Why?
|
| Dopamine | 1 | 2007 | 272 | 0.220 |
Why?
|
| Inflammation | 1 | 2010 | 729 | 0.220 |
Why?
|
| Oleic Acids | 2 | 1994 | 10 | 0.210 |
Why?
|
| Anilides | 2 | 1994 | 28 | 0.210 |
Why?
|
| Alopecia | 1 | 2004 | 10 | 0.210 |
Why?
|
| Hair | 1 | 2004 | 38 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2009 | 379 | 0.210 |
Why?
|
| Cadmium | 1 | 2004 | 54 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 287 | 0.210 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 40 | 0.210 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 318 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 76 | 0.200 |
Why?
|
| Vitamin A Deficiency | 2 | 1996 | 13 | 0.200 |
Why?
|
| Phospholipids | 2 | 2002 | 69 | 0.200 |
Why?
|
| Thyronines | 1 | 2002 | 1 | 0.190 |
Why?
|
| Sickle Cell Trait | 2 | 1993 | 19 | 0.190 |
Why?
|
| Diet | 1 | 2008 | 810 | 0.190 |
Why?
|
| Pyrazines | 1 | 2002 | 24 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 64 | 0.180 |
Why?
|
| Calcium | 2 | 2002 | 487 | 0.180 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 3 | 1994 | 5 | 0.180 |
Why?
|
| Smoke | 1 | 2002 | 41 | 0.180 |
Why?
|
| Erythrocyte Membrane | 2 | 1999 | 20 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 1 | 2002 | 74 | 0.180 |
Why?
|
| Antibody Specificity | 1 | 2001 | 76 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1112 | 0.180 |
Why?
|
| Tissue Distribution | 3 | 2011 | 230 | 0.180 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 66 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 134 | 0.170 |
Why?
|
| Female | 14 | 2013 | 24018 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2001 | 108 | 0.170 |
Why?
|
| Protein Kinase C | 1 | 2001 | 124 | 0.170 |
Why?
|
| Base Sequence | 4 | 2005 | 997 | 0.170 |
Why?
|
| Lipid Peroxidation | 4 | 2006 | 141 | 0.170 |
Why?
|
| Drug Carriers | 1 | 2002 | 169 | 0.160 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 5 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 649 | 0.160 |
Why?
|
| Nucleoside-Triphosphatase | 2 | 2012 | 7 | 0.160 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 33 | 0.160 |
Why?
|
| Asthma | 1 | 2003 | 410 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2001 | 301 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2011 | 59 | 0.150 |
Why?
|
| Ceramides | 3 | 2005 | 43 | 0.150 |
Why?
|
| Pulmonary Surfactants | 1 | 1999 | 32 | 0.150 |
Why?
|
| Cyclin D1 | 2 | 2009 | 44 | 0.150 |
Why?
|
| Cholera Toxin | 3 | 2009 | 41 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2009 | 82 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 479 | 0.140 |
Why?
|
| Cyclic AMP | 3 | 2009 | 135 | 0.140 |
Why?
|
| Cholesterol | 2 | 2012 | 230 | 0.140 |
Why?
|
| Humans | 14 | 2014 | 42163 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2012 | 383 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 458 | 0.130 |
Why?
|
| Obesity | 1 | 2005 | 1131 | 0.130 |
Why?
|
| Administration, Inhalation | 2 | 2010 | 92 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2011 | 990 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 729 | 0.130 |
Why?
|
| Microscopy, Electron | 4 | 2005 | 209 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 58 | 0.130 |
Why?
|
| Exercise | 2 | 1993 | 674 | 0.120 |
Why?
|
| Ligands | 2 | 2008 | 387 | 0.120 |
Why?
|
| Microsomes, Liver | 2 | 2001 | 71 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 506 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1265 | 0.120 |
Why?
|
| Adrenal Medulla | 1 | 1994 | 15 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 1848 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1066 | 0.110 |
Why?
|
| Blood Proteins | 2 | 2009 | 75 | 0.110 |
Why?
|
| Vitamin A | 1 | 1995 | 85 | 0.110 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 66 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 1559 | 0.110 |
Why?
|
| Linoleic Acids | 1 | 1994 | 3 | 0.110 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 7 | 0.110 |
Why?
|
| Hyperpigmentation | 1 | 2013 | 10 | 0.110 |
Why?
|
| Dihydroalprenolol | 2 | 2009 | 6 | 0.100 |
Why?
|
| Free Radicals | 3 | 2003 | 72 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 1993 | 35 | 0.100 |
Why?
|
| Tritium | 2 | 2008 | 51 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2003 | 9 | 0.100 |
Why?
|
| Kinetics | 3 | 2007 | 698 | 0.100 |
Why?
|
| Body Weight | 3 | 2005 | 428 | 0.100 |
Why?
|
| Annexins | 1 | 1992 | 6 | 0.100 |
Why?
|
| Cell Line | 3 | 2004 | 1416 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2003 | 54 | 0.100 |
Why?
|
| Caspases | 2 | 2003 | 148 | 0.100 |
Why?
|
| GABA Agonists | 1 | 2012 | 21 | 0.100 |
Why?
|
| Blood Cell Count | 1 | 1992 | 12 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 193 | 0.090 |
Why?
|
| Trachea | 1 | 2011 | 25 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2003 | 168 | 0.090 |
Why?
|
| Permeability | 1 | 2011 | 66 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 86 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 1993 | 170 | 0.090 |
Why?
|
| alpha-Synuclein | 1 | 2011 | 59 | 0.090 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2010 | 3 | 0.090 |
Why?
|
| Neoplasms | 1 | 2002 | 1341 | 0.090 |
Why?
|
| Aging | 2 | 1993 | 764 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 708 | 0.090 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 22 | 0.090 |
Why?
|
| Submandibular Gland | 1 | 1990 | 3 | 0.090 |
Why?
|
| Isoproterenol | 2 | 2001 | 38 | 0.080 |
Why?
|
| Aerosols | 1 | 2010 | 53 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 15 | 0.080 |
Why?
|
| Oxygen | 1 | 1992 | 217 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1188 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 1990 | 15 | 0.080 |
Why?
|
| Glutathione Peroxidase | 4 | 2006 | 100 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 149 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 34 | 0.080 |
Why?
|
| Submitochondrial Particles | 1 | 1989 | 5 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2003 | 355 | 0.080 |
Why?
|
| Catalase | 4 | 2006 | 111 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 74 | 0.080 |
Why?
|
| Meclofenoxate | 1 | 1989 | 2 | 0.080 |
Why?
|
| Glycolates | 1 | 1989 | 6 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 22 | 0.080 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2009 | 5 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 33 | 0.080 |
Why?
|
| Activating Transcription Factors | 1 | 2009 | 5 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2010 | 165 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 28 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 24 | 0.080 |
Why?
|
| Membranes | 1 | 2009 | 18 | 0.080 |
Why?
|
| Apoptosis | 2 | 2010 | 1541 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 180 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 37 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 692 | 0.070 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2008 | 4 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 284 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2010 | 348 | 0.070 |
Why?
|
| Cell Division | 2 | 2002 | 314 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 54 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2005 | 462 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2010 | 733 | 0.070 |
Why?
|
| Polymyxins | 1 | 1987 | 1 | 0.070 |
Why?
|
| Polymyxin B | 1 | 1987 | 8 | 0.070 |
Why?
|
| Dactinomycin | 2 | 2002 | 11 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 162 | 0.070 |
Why?
|
| Acyltransferases | 1 | 1987 | 21 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1554 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2002 | 30 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1999 | 27 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 2598 | 0.070 |
Why?
|
| Food | 1 | 2008 | 102 | 0.070 |
Why?
|
| Motor Activity | 2 | 2007 | 438 | 0.070 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2007 | 27 | 0.070 |
Why?
|
| Phenotype | 1 | 2010 | 774 | 0.070 |
Why?
|
| Cattle | 2 | 2001 | 505 | 0.070 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2007 | 45 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 448 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2009 | 973 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 83 | 0.060 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 37 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 640 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 201 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2006 | 128 | 0.060 |
Why?
|
| DNA | 1 | 2008 | 594 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 366 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 149 | 0.060 |
Why?
|
| Protein Binding | 1 | 2008 | 1076 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 295 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 34 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 46 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2006 | 198 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2004 | 92 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 51 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 452 | 0.050 |
Why?
|
| Risk Factors | 1 | 2012 | 3942 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 279 | 0.050 |
Why?
|
| Erythrocyte Count | 2 | 1993 | 11 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 23 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 90 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 71 | 0.050 |
Why?
|
| RNA Probes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Thiones | 1 | 2002 | 5 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2002 | 53 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 522 | 0.050 |
Why?
|
| Annexin A1 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pyruvaldehyde | 1 | 2002 | 2 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2002 | 44 | 0.050 |
Why?
|
| Thiophenes | 1 | 2002 | 30 | 0.050 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 2 | 1993 | 10 | 0.050 |
Why?
|
| NADP | 2 | 1993 | 37 | 0.050 |
Why?
|
| Serotonin | 1 | 2001 | 125 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 132 | 0.040 |
Why?
|
| Pregnancy | 3 | 1991 | 1737 | 0.040 |
Why?
|
| Cell Survival | 1 | 2004 | 934 | 0.040 |
Why?
|
| Aorta | 1 | 2001 | 197 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 136 | 0.040 |
Why?
|
| Protein Transport | 1 | 2001 | 295 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 1990 | 79 | 0.040 |
Why?
|
| Lipids | 1 | 2002 | 256 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 199 | 0.040 |
Why?
|
| Epinephrine | 1 | 1999 | 37 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 19 | 0.040 |
Why?
|
| Densitometry | 1 | 1999 | 14 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 933 | 0.040 |
Why?
|
| Water | 1 | 2002 | 314 | 0.040 |
Why?
|
| Cell Membrane | 2 | 1994 | 400 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 599 | 0.040 |
Why?
|
| Lasers | 1 | 1999 | 57 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 198 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1997 | 21 | 0.040 |
Why?
|
| Gene Library | 1 | 1997 | 60 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 195 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1617 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1996 | 66 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 454 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 508 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1999 | 548 | 0.030 |
Why?
|
| Atenolol | 1 | 1994 | 4 | 0.030 |
Why?
|
| Propanolamines | 1 | 1994 | 13 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 107 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 54 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 1994 | 20 | 0.030 |
Why?
|
| Brassica | 1 | 1994 | 16 | 0.030 |
Why?
|
| Plant Oils | 1 | 1994 | 20 | 0.030 |
Why?
|
| Dermatitis | 1 | 2013 | 10 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 1993 | 2 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 63 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 58 | 0.030 |
Why?
|
| Cotinine | 1 | 1993 | 44 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 1993 | 4 | 0.030 |
Why?
|
| Melanins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Choline | 1 | 1993 | 61 | 0.020 |
Why?
|
| Hemolysis | 1 | 1993 | 59 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 142 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 140 | 0.020 |
Why?
|
| Cytosol | 1 | 1992 | 98 | 0.020 |
Why?
|
| Adult | 3 | 2013 | 13458 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1992 | 12 | 0.020 |
Why?
|
| Hematocrit | 1 | 1992 | 25 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 68 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1992 | 112 | 0.020 |
Why?
|
| Diglycerides | 1 | 1991 | 9 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 456 | 0.020 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 1990 | 2 | 0.020 |
Why?
|
| Fetus | 1 | 1991 | 101 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 217 | 0.020 |
Why?
|
| NAD | 1 | 1990 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1058 | 0.020 |
Why?
|
| Convulsants | 1 | 1989 | 5 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 37 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 44 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1990 | 108 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 599 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 1988 | 90 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 57 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 99 | 0.020 |
Why?
|
| Glutathione | 1 | 1988 | 170 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2006 | 13 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2006 | 25 | 0.020 |
Why?
|
| Enzymes | 1 | 2006 | 34 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 256 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 108 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 156 | 0.010 |
Why?
|
| Binding Sites | 1 | 1987 | 670 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 273 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4936 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5950 | 0.010 |
Why?
|